- SARS-CoV-2 mRNA Vaccination Is Not Associated With the Risk of Allosensitization in Patients Awaiting Kidney Transplantation2022 | Central Library of Charles University
- First Booster of SARS-COV-2 mRNA Vaccine Is Not Associated With Alloimmunization and Subclinical Injury of Kidney Allograft2023 | Central Library of Charles University
- Safety and efficacy of one and two booster doses of SARS-CoV-2 mRNA vaccines in kidney transplant recipients: A randomized clinical trial2023 | Faculty of Medicine in Pilsen
- The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients2023 | Third Faculty of Medicine, Central Library of Charles University
- Cellular and humoral immune response to SARS-CoV-2 mRNA vaccines in patients treated with either Ibrutinib or Rituximab2023 | Third Faculty of Medicine
- Declining neutralizing antibody levels after SARS-CoV-2 mRNA vaccination: observational data from community point-of-care testing service in Brno, Czechia2022 | First Faculty of Medicine
- Immunity following SARS-CoV-2 vaccination in autoimmune neurological disorders treated with rituximab or ocrelizumab2023 | First Faculty of Medicine
- Insufficient response to mRNA SARS-CoV-2 vaccine and high incidence of severe COVID-19 in kidney transplant recipients during pandemic2022 | Faculty of Medicine in Pilsen
